Eric Lefkofsky seeks to make cancer into a benign condition

The strides that have been made in cancer treatment throughout the 20th century have been absolutely astounding. Many diseases that were previously considered invariably fatal were suddenly able to be effectively treated and even cured. However, most of the gains in survivability across many different types of cancer were primarily due to the crude treatments of radiation, chemotherapy and surgery. While these methods all proved to be enormously effective, particularly for certain subtypes of cancer, they were nevertheless crude methods with horrendous side effects.

 

It wasn’t until the early 1990s that a new form of cancer treatment began to be devised. Broadley known as precision medicine, these new targeted cancer therapies promised the ability to narrowly focus on the root cause of the disease, potentially eliminating all of the horrible side effects associated with the old and less nuanced forms of treatment and learn more about Eric Lefkofsky.

 

Precision medicine comes in many shapes, sizes and forms. One of the areas in which precision medicine has seen major strides today is in the area of data application to cancer treatment. Eric Lefkofsky is one of the leading innovators in this area. After having co-founded medical data giant Tempus, Lefkofsky is pushing the boundaries of what’s possible through the marriage of data with modern medical techniques. Lefkofsky seeks to bring the power of modern analytic methods, including the use of machine learning, to oncologists across the country.

 

Through the use of gene sequencing, Lefkofsky hopes to put new tools into the hands of doctors that will allow for a level of granularity in understanding patient profiles and likely treatment outcomes that has never before even been imagined. Because the sequencing of an entire human genome is expected to drop to less than $100 in cost by 2025, Lefkofsky believes that this will provide a treasure trove of data, the likes of which has never been available to physicians and Eric’s lacrosse camp.

 

Tempus is creating systems that will effectively allow physicians to conduct their own large-scale studies through the use of artificial intelligence and simulation, operations that would have previously cost millions of dollars and taken years to complete. It is an exciting time for oncology and more information click here.

More Visit: http://www.chicagobusiness.com/article/20161001/ISSUE01/310019995/can-eric-lefkofsky-save-your-life

Back to Top